eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.
Research Article
Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease
- View ORCID ProfileChristina V. Theodoris1,2,3,
- Ping Zhou1,2,
- Lei Liu1,2,
- Yu Zhang1,2,
- View ORCID ProfileTomohiro Nishino1,2,
- Yu Huang1,2,
- View ORCID ProfileAleksandra Kostina4,
- Sanjeev S. Ranade1,2,
- View ORCID ProfileCasey A. Gifford1,2,
- View ORCID ProfileVladimir Uspenskiy5,
- View ORCID ProfileAnna Malashicheva4,5,6,
- View ORCID ProfileSheng Ding1,2,7,
- View ORCID ProfileDeepak Srivastava1,2,8,*
- 1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
- 2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
- 3Program in Developmental and Stem Cell Biology (DSCB), University of California, San Francisco (UCSF), San Francisco, CA, USA.
- 4Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russia.
- 5Almazov Federal Medical Research Centre, Saint Petersburg, Russia.
- 6Saint Petersburg State University, Saint Petersburg, Russia.
- 7Department of Pharmaceutical Chemistry, UCSF, San Francisco, CA, USA.
- 8Department of Pediatrics, Department of Biochemistry and Biophysics, UCSF, San Francisco, CA, USA.
- ↵*Corresponding author. Email: dsrivastava{at}gladstone.ucsf.edu
See allHide authors and affiliations
Science 12 Feb 2021:
Vol. 371, Issue 6530, eabd0724
DOI: 10.1126/science.abd0724
Vol. 371, Issue 6530, eabd0724
DOI: 10.1126/science.abd0724
Christina V. Theodoris
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
3Program in Developmental and Stem Cell Biology (DSCB), University of California, San Francisco (UCSF), San Francisco, CA, USA.
Ping Zhou
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Lei Liu
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Yu Zhang
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Tomohiro Nishino
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Yu Huang
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Aleksandra Kostina
4Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russia.
Sanjeev S. Ranade
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Casey A. Gifford
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
Vladimir Uspenskiy
5Almazov Federal Medical Research Centre, Saint Petersburg, Russia.
Anna Malashicheva
4Institute of Cytology, Russian Academy of Sciences, Saint Petersburg, Russia.
5Almazov Federal Medical Research Centre, Saint Petersburg, Russia.
6Saint Petersburg State University, Saint Petersburg, Russia.
Sheng Ding
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
7Department of Pharmaceutical Chemistry, UCSF, San Francisco, CA, USA.
Deepak Srivastava
1Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
2Roddenberry Stem Cell Center, Gladstone Institutes, San Francisco, CA, USA.
8Department of Pediatrics, Department of Biochemistry and Biophysics, UCSF, San Francisco, CA, USA.
Submit a Response to This Article
No eLetters have been published for this article.